Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rimma Goldberg

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Gut|February 26, 2015
Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's diseaseJames B Canavan, Cristiano Scottà, Anna Vossenkämper, et al.
Gastroenterology|March 27, 2025
Active Inflammatory Bowel Disease on Intestinal Ultrasound During Pregnancy Is Associated With an Increased Risk of Adverse Pregnancy and Neonatal Outcomes Independent of Clinical and Biochemical Disease ActivityRalley E Prentice, Emma K Flanagan, Emily K Wright, et al.
Frontline Gastroenterology|August 26, 2017
Vedolizumab: early experience and medium-term outcomes from two UK tertiary IBD centresMark A Samaan, Polychronis Pavlidis, Emma Johnston, et al.
Nature Communications|November 14, 2020
Characterization of the pathoimmunology of necrotizing enterocolitis reveals novel therapeutic opportunitiesSteven X Cho, Ina Rudloff, Jason C Lao, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Gut|February 26, 2015
Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's diseaseJames B Canavan, Cristiano Scottà, Anna Vossenkämper, et al.
Gastroenterology|March 27, 2025
Active Inflammatory Bowel Disease on Intestinal Ultrasound During Pregnancy Is Associated With an Increased Risk of Adverse Pregnancy and Neonatal Outcomes Independent of Clinical and Biochemical Disease ActivityRalley E Prentice, Emma K Flanagan, Emily K Wright, et al.
Frontline Gastroenterology|August 26, 2017
Vedolizumab: early experience and medium-term outcomes from two UK tertiary IBD centresMark A Samaan, Polychronis Pavlidis, Emma Johnston, et al.
Nature Communications|November 14, 2020
Characterization of the pathoimmunology of necrotizing enterocolitis reveals novel therapeutic opportunitiesSteven X Cho, Ina Rudloff, Jason C Lao, et al.
Pageof 4